DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Adamas Pharmaceuticals, Inc. (ADMS)
« Back to company indexADMS Chatter Timeline
Stock Ticker for ADMS
Most Active Tweeters for ADMS
| User | Tweets |
|---|---|
| @TheMarketsDaily | 3 |
| @AmericanBanking | 3 |
| @EnterpriseLeade | 2 |
| @registrarjourn | 2 |
| @StockTexts | 2 |
Recent Tweets for ADMS
 |
@AmericanBanking Adamas Pharmaceuticals Inc $ADMS Expected to Announce Earnings of -$0.97 Per Share https://t.co/JK75WR0qDT #stocks June 17th 2019, 12:06pm |
 |
@IRAMarketReport Adamas Pharmaceuticals $ADMS Shares Up 6.7% https://t.co/EeY53fJo14 #markets June 15th 2019, 11:06am |
 |
@chaffeybreeze Adamas Pharmaceuticals $ADMS Shares Up 6.7% https://t.co/RT3z2nEnY2 #stocks June 15th 2019, 11:06am |
 |
@TickerReport Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/flonMUmCO3 June 14th 2019, 3:06am |
 |
@dailypoliticaln Adamas Pharmaceuticals $ADMS Upgraded by Zacks Investment Research to Buy https://t.co/yEMfjucKhq June 14th 2019, 3:06am |
 |
@ConsumerFeed Adamas Pharmaceuticals $ADMS Stock Price Up 6.7% https://t.co/BYeexQKEQv June 13th 2019, 9:06pm |
 |
@InsiderBiotech $ADMS upgraded to "BUY" by Zacks https://t.co/S7XJj9wYT7 June 13th 2019, 8:06am |
 |
@registrarjourn Zacks Investment Research Downgrades Adamas Pharmaceuticals $ADMS to Hold https://t.co/d5OdnQkGfJ June 13th 2019, 2:06am |
 |
@EnterpriseLeade Zacks Investment Research Downgrades Adamas Pharmaceuticals $ADMS to Hold https://t.co/5dJ5GoEhRN June 13th 2019, 2:06am |
 |
@OlympiaReport Adamas Pharmaceuticals $ADMS Upgraded to “Buy” by Zacks Investment Research https://t.co/diSYFUxa5P June 13th 2019, 2:06am |
|
@ConsumerFeed Adamas Pharmaceuticals $ADMS Upgraded by Zacks Investment Research to “Buy” https://t.co/9YTiBaFy6m June 12th 2019, 4:06am |
 |
@TheMarketsDaily Zacks Investment Research Downgrades Adamas Pharmaceuticals $ADMS to Hold https://t.co/bED0HacGOf June 12th 2019, 2:06am |
 |
@WKRBNews Adamas Pharmaceuticals Inc $ADMS Given Average Recommendation of “Hold” by Brokerages https://t.co/C7U7Fh6ex6 #markets June 11th 2019, 8:06pm |
 |
@bbnsnews Zacks Investment Research Upgrades Adamas Pharmaceuticals $ADMS to Buy https://t.co/qSS7hriR3F June 11th 2019, 4:06pm |
 |
@dispatchtribune Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research https://t.co/RMlNUKtTMN June 10th 2019, 4:06pm |
 |
@NewsToDesk $ADMS: ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities …: https://t.co/hx43FIcGWf June 10th 2019, 9:06am |
 |
@storminvestor Brokerages Set Adamas Pharmaceuticals Inc $ADMS Price Target at $20.86 https://t.co/zQS2oQAWw7 #markets June 9th 2019, 1:06pm |
 |
@stocknewstimes Brokerages Set Adamas Pharmaceuticals Inc $ADMS Price Target at $20.86 https://t.co/hsiNa2g7al June 9th 2019, 1:06pm |
 |
@SleekMoneycom Brokerages Set Adamas Pharmaceuticals Inc $ADMS Price Target at $20.86 https://t.co/WD8WmGxr7t #investing June 9th 2019, 1:06pm |
 |
@TranscriptDaily Adamas Pharmaceuticals $ADMS Rating Increased to Buy at Zacks Investment Research https://t.co/QcBeiS0RRr June 9th 2019, 6:06am |
 |
@InsiderAlertsIA $ADMS: New Insider Filing on Chief Commercial Officer VIJAY SHREEDHAR: https://t.co/A7etPGgKcy June 7th 2019, 9:06pm |
 |
@StockTexts $ADMS Adamas Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/oQEAyAQbw4 June 7th 2019, 8:06pm |
 |
@ProTradersNews $ADMS: Adamas Announces New Employment Inducement Grant: https://t.co/0mNqeushW0 June 7th 2019, 5:06pm |
 |
@hiddensmallcaps $ADMS looks like its trying to start bottoming. There's a good article on Seeking Alpha about it recently. Their… https://t.co/yAgrRpS8Or June 7th 2019, 2:06pm |
 |
@ZolmaxNews Adamas Pharmaceuticals Inc $ADMS Receives $20.86 Average PT from Analysts https://t.co/Aer4rAa6Db June 7th 2019, 10:06am |
|
@InsiderBiotech $ADMS Adamas Pharmaceuticals $ADMS Upgraded by Zacks Investment Research to “Buy”; somebody noticed that they have… https://t.co/jNBuT9gQS1 June 7th 2019, 8:06am |
|
@TheMarketsDaily Adamas Pharmaceuticals $ADMS Upgraded by Zacks Investment Research to “Buy” https://t.co/8cag9yBixk June 7th 2019, 5:06am |
|
@InsiderAlertsIA $ADMS: New Insider Filing on Director MARTHA J DEMSKI: https://t.co/2gv2DQZajK June 6th 2019, 4:06pm |
|
@StockTexts $ADMS Adamas Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/7OklZ5EHrI June 6th 2019, 4:06pm |
|
@registrarjourn Adamas Pharmaceuticals $ADMS Stock Rating Upgraded by Zacks Investment Research https://t.co/NURuE2Pnpb June 6th 2019, 6:06am |
|
@EnterpriseLeade Adamas Pharmaceuticals $ADMS Stock Rating Upgraded by Zacks Investment Research https://t.co/wWNq3NpEV7 June 6th 2019, 6:06am |
|
@TheMarketsDaily Research Analysts’ Recent Ratings Updates for Adamas Pharmaceuticals $ADMS https://t.co/kYekAiNr1h June 6th 2019, 4:06am |
|
@AmericanBanking Research Analysts’ Recent Ratings Updates for Adamas Pharmaceuticals $ADMS https://t.co/HRM29OiZt8 #stocks June 6th 2019, 4:06am |
|
@WKRBNews Analysts’ Updated EPS Estimates for June, 5th $ADMS, ANZBY, AOSL, AQN, ARPO, ASEKY, ASR, ASV, AT1, ATNI https://t.co/t5ewBq8SZG #markets June 5th 2019, 5:06pm |
 |
@fintel_io Also, if you are new to $ADMS here's some background for you https://t.co/VXYpOY5OBp June 5th 2019, 5:06pm |
|
@fintel_io $ADMS / Adamas Pharmaceuticals files form 8-K https://t.co/HDmsEyIsrs - Submission of Matters to a Vote of Security Holders June 5th 2019, 5:06pm |
 |
@Stock_News_Now $ADMS: New SEC Filing for ADMS: Form 8-K (No. 0001328143-19-000029): https://t.co/I07F4X3Xs6 June 5th 2019, 5:06pm |
 |
@filingsdb New Form 8-K filed by Adamas Pharmaceuticals Inc $ADMS - https://t.co/RYYYQJCwMH June 5th 2019, 4:06pm |
 |
@ThisLincolnian Adamas Pharmaceuticals Inc $ADMS Receives Consensus Rating of “Hold” from Analysts https://t.co/akNZIcIrUA June 4th 2019, 12:06pm |
|
@AmericanBanking Adamas Pharmaceuticals Inc $ADMS Receives Consensus Rating of “Hold” from Brokerages https://t.co/mdBF5PH3Ld #stocks June 4th 2019, 12:06pm |
 |
@StockNewsNow $ADMS Adamas to Present at Upcoming JMP Investor Conference https://t.co/rLddYFu6r9 June 3rd 2019, 5:06pm |
|
@stocknewstimes Adamas Pharmaceuticals $ADMS Lowered to Hold at Zacks Investment Research https://t.co/t7RaTQNvum June 3rd 2019, 2:06am |
|
@SleekMoneycom Adamas Pharmaceuticals $ADMS Lowered to Hold at Zacks Investment Research https://t.co/2B3XOv3hnc #investing June 3rd 2019, 2:06am |
|
@TheMarketsDaily Adamas Pharmaceuticals $ADMS Lowered to Hold at Zacks Investment Research https://t.co/kxv8l4gAob June 3rd 2019, 2:06am |
 |
@macondailynews Adamas Pharmaceuticals $ADMS Rating Increased to Buy at Zacks Investment Research https://t.co/Z6thTJ0WgE June 2nd 2019, 6:06am |
 |
@dakotafinancial Adamas Pharmaceuticals $ADMS Rating Increased to Buy at Zacks Investment Research https://t.co/KAO9fc40qO June 2nd 2019, 6:06am |
|
@registrarjourn Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research to Hold https://t.co/3vmj5umBiM June 2nd 2019, 6:06am |
|
@EnterpriseLeade Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research to Hold https://t.co/s9gA8v3obx June 2nd 2019, 6:06am |
|
@ThisLincolnian -$0.97 EPS Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/rwv6ov4wku June 1st 2019, 6:06pm |
|
@registrarjourn Adamas Pharmaceuticals $ADMS Upgraded to Buy by Zacks Investment Research https://t.co/qMl6kJaqjW June 1st 2019, 5:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.